Showing results (121-130 of 835) with videos related to
Sort By:
Pageof 84
Movement Disorders : Official Journal of the Movement Disorder Society|February 24, 2005
Corticobasal syndrome with novel argyrophilic glial inclusionsGregory A Rippon, S M Staugaitis, Steven S M Chin, et al.Archives of Neurology|May 1, 1995
Neuropsychologic impairment in early HIV infection. A risk factor for work disabilityS M Albert, K Marder, G Dooneief, et al.The Journal of Steroid Biochemistry and Molecular Biology|October 13, 2012
Vitamin D less-calcemic analog modulates the expression of estrogen receptors, vitamin D receptor and 1α-hydroxylase 25-hydroxy vitamin D in human thyroid cancer cell linesD Somjen, M Grafi-Cohen, G H Posner, et al.Journal of Medicinal Chemistry|October 11, 2007
Low-calcemic, highly antiproliferative, 23-oxa ether analogs of the natural hormone 1 alpha,25-dihydroxyvitamin D3: design, synthesis, and preliminary biological evaluationKimberly S Petersen, Patrick M Dolan, Thomas W Kensler, et al.Journal of Medicinal Chemistry|April 4, 1998
Design, synthesis, derivatization, and structure-activity relationships of simplified, tricyclic, 1,2,4-trioxane alcohol analogues of the antimalarial artemisininJ N Cumming, D Wang, S B Park, et al.Parasitology Today (Personal Ed.)|February 1, 1996
Second-generation antimalarial endoperoxidesS R Meshnick, C W Jefford, G H Posner, et al.International Journal of Cell Biology|January 30, 2010
The response of creatine kinase specific activity in rat pituitary to estrogenic compounds and vitamin d less-calcemic analogsD Somjen, N Mirsky, S Tamir, et al.The Journal of Organic Chemistry|October 2, 2001
Iron(II)-induced degradation of antimalarial beta-sulfonyl endoperoxides: evidence for the generation of potentially cytotoxic carbocationsA M Szpilman, E E Korshin, R Hoos, et al.Innovations (Philadelphia, Pa.)|December 15, 2015
Robotically Assisted Bilateral Bronchoplasty for TracheobronchomalaciaJohn F Lazar, David H Posner, Wojciech Palka, et al.The Journal of Steroid Biochemistry and Molecular Biology|April 16, 2004
Treatment with non-hypercalcemic analogs of 1,25-dihydroxyvitamin D3 increases responsiveness to 17beta-estradiol, dihydrotestosterone or raloxifene in primary human osteoblastsSara Katzburg, David Hendel, Anna Waisman, et al.Pageof 84